zelenectide pevedotin
zelenectide pevedotin: sourced relationships with 1 company · 2 clinical trials tracked.
zelenectide pevedotin evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
How could zelenectide pevedotin → BCYC affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence4 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) metastatic urothelial cancer | Phase 2 |
| BICYCLE THERAPEUTICS PLC (BCYC) High Nectin-4 expressing tumors; treatment of adult patients… | Phase 2 |
Clinical Trial Registry Records (2)
Bicycle Continued Access Protocol (BiCAP) for Participants Receiving a Bicycle Investigational Product on a BicycleTx Limited-Sponsored Study
Primary endpoint: Monitor safety for participants receiving a Bicycle investigational product
Phase 2 Study of Zelenectide Pevedotin in Participants With Previously-Treated NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer
Primary endpoint: Objective response rate (ORR) per Response Evaluation Criteria in Solid Tumors, version 1.1 (RECIST 1.1) as assessed by Investigator
Frequently asked questions
Which companies have sourced relationships with zelenectide pevedotin?
zelenectide pevedotin has dated SEC/FDA relationship records for BICYCLE THERAPEUTICS PLC.
How many clinical trials involve zelenectide pevedotin?
BioSniper tracks 2 clinical trials involving zelenectide pevedotin.